$ABT stock has now risen 2% today, according to our price data from Polygon. There has been approximately $552,722,791 of trading volume.
It has been the 64th most-searched ticker on Quiver Quantitative over the last day, out of 10,451 total tickers searched.
Here is what we see in our data on $ABT (you can track the company live on Quiver's $ABT stock page):
$ABT Insider Trading Activity
$ABT insiders have traded $ABT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:
- PHILIP P BOUDREAU (EVP AND CFO) sold 5,550 shares for an estimated $746,758
- ERIC SHROFF (Senior Vice President) sold 1,586 shares for an estimated $203,042
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABT Hedge Fund Activity
We have seen 1,365 institutional investors add shares of $ABT stock to their portfolio, and 1,548 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 9,921,282 shares (-25.2%) from their portfolio in Q3 2025, for an estimated $1,328,856,511
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 9,402,356 shares (+112.4%) to their portfolio in Q3 2025, for an estimated $1,259,351,562
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 8,163,796 shares (+64.0%) to their portfolio in Q3 2025, for an estimated $1,093,458,836
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,451,244 shares (+52.7%) to their portfolio in Q3 2025, for an estimated $730,139,621
- INVESCO LTD. added 4,713,135 shares (+51.0%) to their portfolio in Q3 2025, for an estimated $631,277,301
- MORGAN STANLEY added 3,428,144 shares (+9.7%) to their portfolio in Q3 2025, for an estimated $459,165,607
- POLEN CAPITAL MANAGEMENT LLC removed 3,248,894 shares (-30.5%) from their portfolio in Q3 2025, for an estimated $435,156,862
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABT Revenue
$ABT had revenues of $11.4B in Q3 2025. This is an increase of 6.9% from the same period in the prior year.
You can track ABT financials on Quiver Quantitative's ABT stock page.
$ABT Government Contracts
We have seen $125,021,148 of award payments to $ABT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VISN 9 CHEMISTRY AUTOMATION COST PER RESULTS REPORTABLE: $4,510,608
- VISN1 BPA FOR IMMUNOCHEMISTRY CPRR TESTING ADDING EQUIPMENT FOR MANCHESTER NH VAMC - WITHIN ORIGINAL SCOPE: $4,335,000
- CHEMISTRY IMMUNOASSAY ANALYZER COST PER REPORTABLE RESULT (CPRR) PRICE SCHEDULE UPDATE: $4,000,483
- LAB CHEMISTRY SERVICES: $3,766,564
- CIVILIAN DRUG FREE WORKPLACE COLLECTIONS AND MEDICAL REVIEW OFFICER SUPPORT SERVICES: $2,787,929
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ABT Congressional Stock Trading
Members of Congress have traded $ABT stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 10/06.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 07/21.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 07/18.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABT Analyst Ratings
Wall Street analysts have issued reports on $ABT in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/20/2025
- Barclays issued a "Overweight" rating on 10/17/2025
- RBC Capital issued a "Outperform" rating on 10/16/2025
- Evercore ISI Group issued a "Outperform" rating on 10/16/2025
- Raymond James issued a "Outperform" rating on 10/16/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Benchmark issued a "Buy" rating on 10/10/2025
To track analyst ratings and price targets for $ABT, check out Quiver Quantitative's $ABT forecast page.
$ABT Price Targets
Multiple analysts have issued price targets for $ABT recently. We have seen 10 analysts offer price targets for $ABT in the last 6 months, with a median target of $145.0.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $145.0 on 11/20/2025
- Matt Miksic from Barclays set a target price of $162.0 on 10/17/2025
- Jayson Bedford from Raymond James set a target price of $146.0 on 10/16/2025
- Shagun Singh from RBC Capital set a target price of $147.0 on 10/16/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $146.0 on 10/16/2025
- Vijay Kumar from Evercore ISI Group set a target price of $142.0 on 10/16/2025
- Bruce Jackson from Benchmark set a target price of $145.0 on 10/10/2025
You can track data on $ABT on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
